Pfizer-Allergan deal is a ‘travesty’ - Icahn
Activist investor Carl Icahn argues that deal will open the floodgates for other companies to leave the US
Investors and directors discover it’s good to talk
The Bottom Line: a little communication with shareholders would go a long way
Battle for Dell yet to power down
When a takeover deal was announced in February, Dell looked set to be handed over to its founder, but billionaire Carl Icahn remains resolute in his opposition
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Stardust
Inquests into the nightclub fire that led to the deaths of 48 people
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices